1424-P: Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials to the Type 2 Diabetes Population in China

Glucagon Like Peptide ◽

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States

Diabetes Obesity and Metabolism ◽

10.1111/dom.13649 ◽

2019 ◽

Vol 21 (6) ◽

pp. 1299-1304 ◽

Cited By ~ 15

Author(s):

Kristina S. Boye ◽

Matthew C. Riddle ◽

Hertzel C. Gerstein ◽

Reema Mody ◽

Luis‐Emilio Garcia‐Perez ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

The United States ◽

Cardiovascular Outcome ◽

Glucagon Like Peptide ◽

Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.011 ◽

2020 ◽

Vol 44 (1) ◽

pp. 68-77 ◽

Cited By ~ 4

Author(s):

Elodie M. Varin ◽

Brent A. McLean ◽

Julie A. Lovshin

Keyword(s):

Type 2 Diabetes ◽

Adult Patients ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

CARDIOVASCULAR BENEFIT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN FEMALE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RECENT CARDIOVASCULAR OUTCOME TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(19)30847-2 ◽

2019 ◽

Vol 73 (9) ◽

pp. 239

Author(s):

David Aguilar ◽

Efstratios Koutroumpakis ◽

Heinrich Taegtmeyer

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Cardiovascular Benefit

Comparative safety of glucagon like peptide‑1 receptor agonists in patients with type 2 diabetes: a network meta-analysis of cardiovascular outcome trials

10.37766/inplasy2020.8.0122 ◽

2020 ◽

Author(s):

Chuanjun Zhuo ◽

Hongjun Tian ◽

Lina Wang ◽

Xiangyang Gao ◽

Li Ding ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Comparative Safety

Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-021-01079-x ◽

2021 ◽

Author(s):

Xiaoling Cai ◽

Linong Ji

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Outcome ◽

Chinese Patients ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Abstract P077: Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Black Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Recent Cardiovascular Outcome Trials

Circulation ◽

10.1161/circ.139.suppl_1.p077 ◽

2019 ◽

Vol 139 (Suppl_1) ◽

Author(s):

Efstratios Koutroumpakis ◽

Heinrich Taegtmeyer ◽

David Aguilar

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Black Patients ◽

Glucagon Like Peptide ◽

Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis

BMC Pharmacology and Toxicology ◽

10.1186/s40360-018-0246-x ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 6

Author(s):

Xiaowen Zhang ◽

Fei Shao ◽

Lin Zhu ◽

Yuyang Ze ◽

Dalong Zhu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Sequential Analysis ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Trial Sequential Analysis ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Combination of Premixed Insulin with Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) for Uncontrolled Type 2 Diabetes Mellitus (T2DM) Patients

Diabetes ◽

10.2337/db18-2231-pub ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 2231-PUB

Author(s):

SASAN FAZELI ◽

NICOLE EHRHARDT

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Premixed Insulin ◽

Glucagon Like Peptide ◽

938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes

Diabetes ◽

10.2337/db20-938-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 938-P

Author(s):

RALEIGH E. MALIK ◽

REEMA MODY ◽

MAUREEN J. LAGE ◽

KRISTINA BOYE

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Timing Of Initiation ◽

The Relationship

Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies

Diabetes Therapy ◽

10.1007/s13300-021-01021-1 ◽

2021 ◽

Author(s):

Thomas M. Caparrotta ◽

Jack B. Templeton ◽

Thomas A. Clay ◽

Sarah H. Wild ◽

Rebecca M. Reynolds ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Observational Studies ◽

Receptor Agonist ◽

Population Based ◽

Glucagon Like Peptide ◽